common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

A Safety Study of LY3372689 in Healthy Participants

This study is being conducted to determine the safety profile of the study drug after it is given by mouth to healthy participants. Blood tests will be performed to check how much LY3372689 gets into the bloodstream and how long the body takes to get rid of it. Each enrolled participant will receive multiple doses of LY3372689 or placebo and will remain in the study for up to eight weeks.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - LY3372689

Administered orally

Drug - Placebo

Administered orally

participant.views.study.view.additional

participant.views.study.view.scientific-title

Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3372689

common.study.values.clinical-trial-id

NCT04106206

participant.views.study.view.id

b2kMKd